Commercializing Innovation: Prof. Doug Melton and Semma Therapeutics


Monday, April 24, 2017, 4:00pm to 6:00pm


Biolabs 1080, 16 Divinity Ave., Cambridge

Featuring cofounders of Harvard-launched startup Semma Therapeutics:

  • Douglas A. Melton, PhD, Xander University Professor and Thomas Dudley Cabot Professor in the Natural Sciences, Harvard University; co-director of the Harvard Stem Cell Institute
  • Felicia Pagliuca, PhD, Vice President of Cell Biology Research and Development, Semma Therapeutics
  • Robert Millman, JD, CEO of Semma Therapeutics

The Commercializing Innovation speaker series is primarily intended for Harvard University faculty, postdoctoral researchers, and graduate students who are interested in learning about technology commercialization, careers outside of academia, and scientific entrepreneurship. However, the event is open to all.

To register, go here

Hosted by Harvard Office of Technology Development and the FAS Office of Postdoctoral Affairs.